Aganos, Karlyn Joy .

HRN: 29-22-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2026
CO-AMOXICLAV 625MG (TAB)
07/22/2026
07/28/2026
ORAL
625mg
Q12hrs
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: